Loading...
Loading...
Contributors:
Dataset URI:
9785bcfb-b395-4624-a0f8-bb7b5752c1fcThis Phase IIb study in HIV-infected antiretroviral naive subjects will select an optimal once daily dose of GSK1349572 from a range of doses for future evaluation.
Keyword(s):
efavirenz; GSK1349572; HIV infection; Infection, Human Immunodeficiency Virus; Infectious Disease.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)